GleamWall
中文EN

MDT Medtronic plc

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1613103 · Fiscal year ends 04/24

Financial factors as of 2026-07-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY12.3%
TTM EPS YoY12.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR13.1%

Margins

Gross margin65.0%
Operating margin18.1%
Net margin13.9%
FCF margin16.3%
EBITDA margin23.5%

Returns

ROE10.7%
ROA5.7%
ROIC (approx.)7.1%
Asset turnover0.41x

Leverage & solvency

Liabilities / assets45.5%
Debt / equity0.56x
Current ratio2.07x
Interest coverage9.37x

Cash quality & payout

Operating cash flow / net income1.54x
Accruals ratio-3.0%
Payout ratio69.8%
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-04-24FY20252025-04-25
Income statement
Revenue$36.36B$33.54B
Cost of revenue$12.72B$11.63B
Gross profit$23.64B$21.91B
R&D expense$2.87B$2.73B
SG&A expense$11.78B$10.85B
Operating income$6.47B$5.96B
Interest expense$715.00M$729.00M
Pretax income$6.14B$5.63B
Income tax$1.30B$936.00M
Net income$4.80B$4.66B
EBITDA$9.43B$8.82B
EPS (basic)3.753.63
EPS (diluted)3.733.61
Dividends declared per share2.842.80
Weighted avg. shares (diluted)1.29B1.29B
Banking
Net interest income$383.00M$511.00M
Balance sheet
Cash & equivalents$1.95B$2.22B
Short-term investments$7.27B$6.75B
Receivables$6.64B$6.51B
Inventory$5.95B$5.48B
Current assets$24.79B$23.81B
PP&E, net$7.42B$6.84B
Goodwill$42.59B$41.74B
Intangibles$10.15B$11.67B
Total assets$93.03B$91.68B
Current liabilities$11.66B$12.88B
Short-term debt$1.79B$2.87B
Long-term debt$26.17B$25.64B
Total debt$27.96B$28.52B
Total liabilities$42.96B$43.42B
Shareholders' equity$49.46B$48.02B
Net debt$26.01B$26.30B
Shares outstanding1.28B1.28B
Cash flow statement
Operating cash flow$7.33B$7.04B
Capital expenditure$1.90B$1.86B
Free cash flow$5.43B$5.18B
Investing cash flow-$2.93B-$1.94B
Financing cash flow-$4.75B-$4.36B
Depreciation & amortization$2.96B$2.86B
Stock-based compensation$457.00M$429.00M
Dividends paid$3.64B$3.59B
Share buybacks$1.03B$3.23B

Free plan shows the latest 2 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.